Insider Transactions in Q2 2025 at Genelux Corp (GNLX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2025
|
John Thomas |
SELL
Bona fide gift
|
Direct |
25,000
-4.95%
|
-
|
|
May 12
2025
|
Ralph Smalling Head of Regulatory |
SELL
Open market or private sale
|
Direct |
1,259
-3.5%
|
$2,518
$2.92 P/Share
|
|
May 12
2025
|
Joseph Cappello VP, Pharmaceutical Development |
SELL
Open market or private sale
|
Direct |
4,737
-8.31%
|
$9,474
$2.92 P/Share
|
|
May 12
2025
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
5,579
-10.48%
|
$11,158
$2.92 P/Share
|
|
May 12
2025
|
Thomas Zindrick President and CEO |
SELL
Open market or private sale
|
Direct |
10,764
-5.32%
|
$21,528
$2.92 P/Share
|
|
May 12
2025
|
Sean Ryder General Counsel |
SELL
Open market or private sale
|
Direct |
4,475
-8.59%
|
$8,950
$2.92 P/Share
|